Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    17895322 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
Conditions: Hypoglycemia;   Evidence of Previous Gastric Surgery
Intervention: Drug: Pramlintide
2 Enrolling by invitation Human Intestinal Peptides Evaluation and Research
Conditions: Obesity;   Diabetes Mellitus, Type 2
Intervention: Other: blood sample analysis

Study has passed its completion date and status has not been verified in more than two years.